The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01047878
Recruitment Status : Unknown
Verified April 2016 by Stanford University. Recruitment status was: Recruiting
To determine whether gene expression analysis of primary tumor samples before and after chemotherapy are predictive of long-term survival in pediatric patients with bone sarcomas (Ewings sarcoma (ES) and Osteosarcoma(OS)).
% necrosis post chemotherapy [ Time Frame: his is measured at the time of sample collection since we are looking for % necrosis in the sample we are collecting ]
overall survival and event free survival [ Time Frame: This is measured at the time the patient dies, or at the time when patient relapses from their disease. There is no set time since this outcome is individually assessed. ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
up to 18 Years (Child, Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
All patients with bone x-rays suggestive of a malignant bone tumor
Inclusion Criteria:All patients with bone x-rays suggestive of a malignant bone tumor
Exclusion Criteria:Patients with a known diagnosis of cancer.